FIBROGEN INC(NASDAQ:FGEN) stock News

FGEN Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: FibroGen, Inc.

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

2 months ago - By: FibroGen, Inc.

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

2 months ago - By: FibroGen, Inc.

FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: Stocktwits - Mentions: AZN

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca

2 months ago - By: FibroGen, Inc.

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

2 months ago - By: Benzinga - Mentions: PRPH AZTR MYO TLRY ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

2 months ago - By: Benzinga

Uncovering Potential: FibroGen's Earnings Preview

2 months ago - By: Zacks Investment Research - Mentions: AIM

FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: FibroGen, Inc.

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: FibroGen, Inc.

FibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic Syndromes

3 months ago - By: FibroGen, Inc.

FibroGen to Report Second Quarter 2025 Financial Results

3 months ago - By: The Motley Fool - Mentions: VRTX PROK

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz

4 months ago - By: FibroGen, Inc.

FibroGen Announces 1-for-25 Reverse Stock Split

4 months ago - By: FibroGen, Inc.

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors

5 months ago - By: Zacks Investment Research - Mentions: MDWD

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates

5 months ago - By: FibroGen, Inc.

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: Zacks Investment Research - Mentions: STVN

Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates

6 months ago - By: FibroGen, Inc.

FibroGen to Report First Quarter 2025 Financial Results

7 months ago - By: FibroGen, Inc.

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

7 months ago - By: FibroGen, Inc.

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

7 months ago - By: FibroGen, Inc.

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results

8 months ago - By: FibroGen, Inc.

FIBROGEN INC (FGEN) Stock News

FGEN Latest News, Press Relases and Analysis

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Uncovering Potential: FibroGen's Earnings Preview

FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

FibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic Syndromes

FibroGen to Report Second Quarter 2025 Financial Results

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz

FibroGen Announces 1-for-25 Reverse Stock Split

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update

Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates

FibroGen to Report First Quarter 2025 Financial Results

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results